NATCO PHARMA LTD.
BSE: 524816
Shareholding Trends
Ownership split
PromoterPublicOthers
Institutional detail
FII / FPIDII
Q4 FY2026
Corporate Events
Board MeetingNATCOPHARM
202629May
Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗ Board MeetingNATCOPHARM
202624Mar
Board Meeting
To consider and approve the Scheme of Arrangement for the de…
BSE Filing ↗ Board MeetingNATCOPHARM
202427May
Board Meeting
Approval of the Audited Financial Results for the quarter an…
BSE Filing ↗ Board MeetingNATCOPHARM
202414Feb
Board Meeting
Consideration of Unaudited Financial Results for the quarter…
BSE Filing ↗ Board MeetingNATCOPHARM
202314Nov
Board Meeting
consideration and approval of The Unaudited Financial Result…
BSE Filing ↗